435 related articles for article (PubMed ID: 16889456)
1. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients.
Ascher-Svanum H; Peng X; Faries D; Montgomery W; Haddad PM
BMC Psychiatry; 2009 Jul; 9():46. PubMed ID: 19640279
[TBL] [Abstract][Full Text] [Related]
3. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
Ascher-Svanum H; Faries DE; Zhu B; Ernst FR; Swartz MS; Swanson JW
J Clin Psychiatry; 2006 Mar; 67(3):453-60. PubMed ID: 16649833
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of barriers to medication adherence in schizophrenia.
Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.
Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV
J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599
[TBL] [Abstract][Full Text] [Related]
6. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.
Perkins DO; Gu H; Weiden PJ; McEvoy JP; Hamer RM; Lieberman JA;
J Clin Psychiatry; 2008 Jan; 69(1):106-13. PubMed ID: 18312044
[TBL] [Abstract][Full Text] [Related]
7. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
8. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response.
Lindenmayer JP; Liu-Seifert H; Kulkarni PM; Kinon BJ; Stauffer V; Edwards SE; Chen L; Adams DH; Ascher-Svanum H; Buckley PF; Citrome L; Volavka J
J Clin Psychiatry; 2009 Jul; 70(7):990-6. PubMed ID: 19497244
[TBL] [Abstract][Full Text] [Related]
9. Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study.
Grunebaum MF; Weiden PJ; Olfson M
J Clin Psychiatry; 2001 May; 62(5):394-9; quiz 400-1. PubMed ID: 11411825
[TBL] [Abstract][Full Text] [Related]
10. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
[TBL] [Abstract][Full Text] [Related]
11. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
Offord S; Lin J; Mirski D; Wong B
Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
[TBL] [Abstract][Full Text] [Related]
12. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics.
Lang K; Meyers JL; Korn JR; Lee S; Sikirica M; Crivera C; Dirani R; Menzin J
Psychiatr Serv; 2010 Dec; 61(12):1239-47. PubMed ID: 21123409
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
Shi L; Ascher-Svanum H; Zhu B; Faries D; Montgomery W; Marder SR
Psychiatr Serv; 2007 Apr; 58(4):482-8. PubMed ID: 17412849
[TBL] [Abstract][Full Text] [Related]
14. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients.
Sapra M; Weiden PJ; Schooler NR; Sunakawa-McMillan A; Uzenoff S; Burkholder P
Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):199-206. PubMed ID: 23428784
[TBL] [Abstract][Full Text] [Related]
15. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
16. Assessment of medication adherence in patients with schizophrenia: the Achilles heel of adherence research.
Kikkert MJ; Barbui C; Koeter MW; David AS; Leese M; Tansella M; Gieler A; Puschner B; Schene AH
J Nerv Ment Dis; 2008 Apr; 196(4):274-81. PubMed ID: 18414121
[TBL] [Abstract][Full Text] [Related]
17. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
[TBL] [Abstract][Full Text] [Related]
18. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
19. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
Kane JM
J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.
de Haan L; van Amelsvoort T; Dingemans P; Linszen D
Pharmacopsychiatry; 2007 Nov; 40(6):264-8. PubMed ID: 18030650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
